4
Changes in Ownership
Inhibitor Therapeutics, Inc. Filed Acc 0001144204-18-007442
Director bought 600,000 shares at $162,660.00 ($97,596,000,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cross Stefan Director | 2017-12-19 | Purchase | −600,000 | $162,660.00 | $97,596,000,000 | 0 | D |
| Open-market purchases · 600,000 sh · avg $162,660.00 · $97,596,000,000 | |||||||
Loading xslF345X03/tv485758_4.xml…